Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Instagram ads for skin, hair, and nail supplements often make broad health claims without clear ingredient information, and are not FDA-regulated.

Lavender is widely used for its calming effects and in beauty products, but its medical effectiveness is not fully proven and not FDA-approved.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Exosomes, tiny cell-released particles, may help hair growth, but their exact role is unclear, they're not FDA-approved, and their unregulated use can cause side effects.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Weight-loss drugs are not linked to suicidal thoughts.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Lasers and light treatments are now the most common ways to remove hair.

Urologists should screen for mental health issues before and during finasteride treatment.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Certain drugs can cause eyelid inflammation, so doctors should monitor and educate patients on eyelid care.

Certain compounds can boost hair and nail growth.

Topical finasteride may be safer than oral finasteride, but more research is needed.

Aminoacridine and Minoxidil together show promise for better hair and nail growth.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Minoxidil solution and foam both increase hair growth, but the solution works better than the foam.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Excessive selenium from supplements can be harmful.

Excessive selenium in supplements can cause hair loss and nail issues.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Photobiomodulation is an effective and safe treatment for increasing hair growth in people with hair loss.